Stock 600572 ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang CONBA Pharmaceutical Co.,Ltd.

Equities

600572

CNE000001H86

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
4.9 CNY -0.61% Intraday chart for Zhejiang CONBA Pharmaceutical Co.,Ltd. -3.54% -2.97%
Apr. 19 Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 01 Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024. CI

Business Summary

Zhejiang CONBA Pharmaceutical Co Ltd is a China-based company, principally engaged in the research and development, manufacture and distribution of traditional Chinese medicines, modern phytomedicines and chemical drugs. The Company also provides active ingredients. The Company's products include tablets, capsules, pills, granules, powders, injections, oral solutions, syrups, eye drops, nasal drops, ear drops, ointments and others. Its products are applied in cardiovascular and cerebrovascular diseases, urinary system diseases, digestive diseases, respiratory diseases, endocrine system, nervous system, anti-infection and other treatment areas. The Company also provides value-added services. The Company distributes its products within domestic markets.

Number of employees: 8,411

Sales per Business

CNY in Million2022Weight2023Weight Delta
All types of Traditional Chinese Medicine
53.8 %
- - 3,625 53.8 % -
Special Chemicals
35.5 %
- - 2,391 35.5 % -
Special Health Consumer
8.6 %
478 8.0 % 580 8.6 % +21.36%
Other Business
1.2 %
55 0.9 % 81 1.2 % +46.66%
Other
0.8 %
850 14.2 % 56 0.8 % -93.40%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
6,000 100.0 % 6,733 100.0 % +12.20%

Managers

Managers TitleAgeSince
Guo Liang Luo PSD
 President 62 20-07-21
Ming Chen DFI
 Director of Finance/CFO 48 20-07-21
Zhen Xian Yuan BRD
 Director/Board Member 48 18-04-25
Fang Chen IRC
 Investor Relations Contact - -
Zu Cheng Jin SEC
 Corporate Secretary 49 -

Members of the board

Members of the board TitleAgeSince
Ji Qiang Hu CHM
 Chairman 63 05-04-28
Ming Chen DFI
 Director of Finance/CFO 48 20-07-21
Zuo Jun Dong BRD
 Director/Board Member 54 20-07-21
Zhen Xian Yuan BRD
 Director/Board Member 48 18-04-25
Guo Liang Luo PSD
 President 62 20-07-21
Yong Jiang Wu BRD
 Director/Board Member 61 20-07-21
Chun Xiao Ying CHM
 Chairman 50 20-07-21
Xing Hua Cheng BRD
 Director/Board Member 61 20-07-21
En Liu BRD
 Director/Board Member 61 20-07-21
Shi Shui Yin CHM
 Chairman - 21-09-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,570,037,319 1,533,298,246 ( 59.66 %) 0 59.66 %

Shareholders

NameEquities%Valuation
Zhejiang State-Owned Asset Sup. & Admin. Commission
22.91 %
587,278,040 22.91 % 392 M ¥
Ji Qiang Hu
13.93 %
357,010,256 13.93 % 239 M ¥
China Southern Asset Management Co., Ltd.
2.456 %
62,950,379 2.456 % 42 M ¥
Zhong Ou Asset Management Co., Ltd
2.240 %
57,416,646 2.240 % 38 M ¥
CIB Fund Management Co., Ltd.
2.193 %
56,206,300 2.193 % 38 M ¥
GF Fund Management Co., Ltd.
2.125 %
54,472,512 2.125 % 36 M ¥
First Seafront Fund Management Co., Ltd.
1.630 %
41,769,007 1.630 % 28 M ¥
Kuwait Investment Authority (Investment Management)
1.613 %
41,337,300 1.613 % 28 M ¥
Zhejiang Dahua Investment Development Co. Ltd.
1.440 %
36,903,000 1.440 % 25 M ¥
Hui Ting Cai
1.175 %
30,109,800 1.175 % 20 M ¥

Holdings

NameEquities%Valuation
ZHEJIANG INT'L GROUP CO.,LTD.
23.90%
 48,899,755 23.90% 72,123,716 $

Company contact information

Zhejiang Conba Pharmaceutical Co., Ltd.

No. 568 Binkang Road Binjiang Sci & Tech Economic Park

310052, Hangzhou

+86 571 8777 4710

http://www.conba.com.cn
address Zhejiang CONBA Pharmaceutical Co.,Ltd.(600572)

Group companies

NameCategory and Sector
Kang Jia Medical Technology Ltd.
Kanghe Medical Technology Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Ratings for Zhejiang CONBA Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.9
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. Stock Zhejiang CONBA Pharmaceutical Co.,Ltd.
-2.97% 1.74B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.68% 42.78B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.49% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.91% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.91% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.29% 5.01B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600572 Stock
  4. Company Zhejiang CONBA Pharmaceutical Co.,Ltd.